Patent details

EP3448846 Title: SYNTHESIS OF INDAZOLES

Basic Information

Publication number:
EP3448846
PCT Application Number:
EP2017059744
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP177185584
PCT Publication Number:
WO2017186689
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
SYNTHESIS OF INDAZOLES
French Title of Invention:
SYNTHÈSE D'INDAZOLES
German Title of Invention:
SYNTHESE VON INDAZOLEN
SPC Number:

Dates

Filing date:
25/04/2017
Grant date:
26/05/2021
EP Publication Date:
06/03/2019
PCT Publication Date:
02/11/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
26/05/2021
EP B1 Publication Date:
26/05/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
25/04/2022
Expiration date:
25/04/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
19/05/2021
 
 

Name:
Bayer Pharma Aktiengesellschaft
Address:
Müllerstrasse 178, 13353 Berlin, Germany (DE)

Inventor

1

Name:
PLATZEK, Johannes
Address:
Germany (DE)

2

Name:
THALER, Tobias
Address:
Germany (DE)

3

Name:
GUIMOND, Nicolas
Address:
Germany (DE)

Priority

Priority Number:
16167652
Priority Date:
29/04/2016
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
C07D 401/12; A61K 31/4439; A61P 35/00; A61P 37/00; A61P 9/00; A61P 27/00;

Publication

European Patent Bulletin

Issue number:
202121
Publication date:
26/05/2021
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages